Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Epidemiology
- Suppurative clinical syndromes
- Erysipelas and cellulitis
- Infected wounds
- Necrotising fasciitis
- Treatment of necrotising fasciitis
- Streptococcal toxic shock syndrome
- Risk factors for infections
- Non-suppurative disease
- Group A streptococcus
- Virulence factors
- Virulence factors: Toxins
- Virulence factors: Enzymes
- Diagnosis and treatment
Topics Covered
- Streptococcus pyogenes
- Epidemiology
- Clinical manifestations
- Non-suppurative disease
- Virulence factors
- Diagnosis and treatment
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Fouch, S. (2024, October 31). Streptococcus pyogenes [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 19, 2024, from https://doi.org/10.69645/TCIC7956.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Sarah Fouch has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Other Talks in the Series: Introduction to Microbes
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, everybody. My
name is Dr. Sarah Fouch.
Welcome to this short talk
where we will be considering
group A streptococci or
Streptococcus pyogenes.
We will be considering
the conditions that this
organism is associated with
and the virulence factors that
this organism can produce to
make it such a
successful pathogen.
0:27
When we consider
group A streptococci,
we carry this organism in low
numbers in our oropharynx.
Carriage tends to be seen
normally in children
and young adults.
However, some older adults
can also carry this
organism as well.
Sometimes we can have
transient carriage and
sometimes permanent carriage.
But the carriage will
depend on the antibodies
that are being
produced to the
particular M proteins
that are being expressed
by the organism.
Basically, an individual's
immune system is reducing
the number of organisms
that are being
carried to a low number.
When we think about
how strains are
transferred between
person to person,
this is through
droplet infection.
While I'm talking to you,
I have small droplets
coming out of my mouth.
I'm not spitting
all over the camera
because that would be
particularly unpleasant.
But small droplets are
actually coming out of
my mouth all the time,
particularly, when I say B or P.
If somebody is in
close proximity to me,
and they're able to breathe in
those droplets, and they don't
have antibodies to that
particular M protein
that's being expressed,
they will have an
increased risk of
obtaining an infection.
Group A streptococci
can also be part of
our normal skin flora so
we can have skin
colonisation as well.
Direct contact can also be
an issue with
susceptible individuals.